FindTrial
Sign In

Molecular Detection of epithelial-mesenchymal transition markers in circulating Tumor cells from pancreatic cancer patients: potential role in clinical practice.

A retrospective study regarding to the correlation between circulating tumor cells with clinicalpathological characteristics in pancreatic cancer petients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018513
Enrollment
Unknown
Registered
2018-09-21
Start date
2018-09-20
Completion date
Unknown
Last updated
2018-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer

Interventions

CTC positive/negative:no

Sponsors

Sun Yat-sen Memorial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The pathological diagnoses of all patients were clear and definite. None of the patients received any preoparative chemotherapy or radiotherapy. Follow-up data were carried out completely and OS was defined as the time interval between the date of surgery and the date of death or the end of follow-up.

Exclusion criteria

Exclusion criteria: The pathological diagnosis was not pancreatic adenocarcinoma.

Design outcomes

Primary

MeasureTime frame
overall survival;CTC counter and categary;—

Countries

China

Contacts

Public ContactYimin Liu

Sun Yat-sen Memorial Hospital

liuyimin1995@163.com+86 020-81332533

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026